Director · LIGAND PHARMACEUTICALS INC · Common Stock
Side
M
Value
$32K
Shares
459
Price
$69.51
Executed
May 12, 2026
Disclosed
May 14, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
May 12 executedMay 14, 2026 disclosed
LGND · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Option exercise — administrative, little informational value
Relative size+1 / 25
$32K reported value · 1.1% of prior position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+1 / 15
Routine: 26 prior trades recorded in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Kozarich John W filed this Form 4 reporting a option exercise of LGND on May 12, 2026. It became public on May 14, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Kozarich John Wcik:0001223000
Issuer
LIGAND PHARMACEUTICALS INCcik:0000886163
Revision history · 0
No field has changed since this record was first ingested.
